Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. American Society of Hematology Annual Meeting 2015

    ... and clinical practice to review the contributions of cytogenetics and molecular genetics to the biology of these disorders, and ...

    Page last updated 08/25/2016 - 1:01pm.

  2. Intra-Osseous Co-Transplant of UCB and hMSC

    ... (first complete remission [CR1]) with poor-risk cytogenetics or molecular markers (e.g. fms-related tyrosine kinase 3 [Flt 3] mutation , 11q23, del 5, del 7, complex cytogenetics) Second complete remission (CR2) or third complete ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  3. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... a.  18-81 years of age b.  MDS classification and cytogenetics confirmed within 8 weeks prior to or during screening as ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  4. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... to cytotoxic chemotherapy for another condition, adverse cytogenetics or complex karyotype), or any subjects > 70 years of age with ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  5. Jaroslaw Maciejewski, MD, PhD

    ... various specific aspects of stem cell biology, genetics, cytogenetics and immunobiology. Leadership ...

    Leadership Award last updated 05/02/2016 - 2:27pm.

  6. Allo HSCT Using RIC for Hematological Diseases

    ... high risk CR1 (as evidenced by preceding MDS, high risk cytogenetics , ≥ 2 cycles to obtain CR, erythroblastic or megakaryocytic ... that define high risk CR1 include but are not limited to cytogenetics demonstrating t(9;22), t (1:19), t(4;11), other MLL ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  7. Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

    ... evidenced by preceding MDS, intermediate to high risk cytogenetics , ≥ 2 cycles to obtain CR, erythroblastic or megakaryocytic ...

    Clinical Trial last updated 04/29/2016 - 1:48pm.

  8. RIC Transplant Using Haplo Donors

    ... of the following: treatment-related; monosmy 7, complex cytogenetics or other high risk karyotype; IPSS score of 1.0 or greater; ... of minimal residual disease by flow cytometry , cytogenetics, or FISH Chronic Lymphocytic Leukemia/Prolymphocytic ...

    Clinical Trial last updated 04/29/2016 - 10:52am.

  9. Total Marrow Irradiation for Refractory Acute Leukemia

    ... disease (MRD) by flow cytometry , FISH or cytogenetics Myelodysplastic syndrome ≤ 55 years of age ... minimal residual disease (MRD) by flow cytometry, FISH or cytogenetics Multiple myeloma No prior autologous ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  10. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... myelodysplastic syndromes [MDS], high risk cytogenetics such as those associated with MDS or complex karyotype, > 2 ... leukemia/lymphoma: high risk CR1 as evidenced by high risk cytogenetics (e.g. t(9;22), t(1;19),t(4;11), other mixed-lineage leukemia (MLL) ...

    Clinical Trial last updated 04/29/2016 - 10:06am.